Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Mar 6 2000
Dallas, Texas (March 6, 2000) The Biotechnology Industry Organization (BIO) has named Texas Rep. Brian McCall (R-Plano) as BIO State Legislator of the Year...
Mar 1 2000
WASHINGTON, D.C. (March 1, 2000) In addition to health care, biotechnology's impact on the environment, industrial manufacturing and agriculture will be...
Feb 29 2000
WASHINGTON, D.C. (February 29, 2000) -- The Biotechnology Industry Organization (BIO) has placed on its website (www.bio.org) a BIO 2000 News Room to provide...
Feb 25 2000
WASHINGTON, D.C. (February 25, 2000) Genomics has captured the attention of Wall Street investors and the imagination of others worldwide as researchers near...
Feb 23 2000
WASHINGTON, D.C. (February 23, 2000) The BiotechnologyIndustry Organization (BIO) issued the following statement in response to the bill introduced by U.S....
Feb 17 2000
EXECUTIVE SUMMARY BIO represents over 850 biotechnology companies, academic institutions, state biotechnology centers, and related organizations in 46 states...
Feb 14 2000
WASHINGTON, D.C. (February 14, 2000) - Christopher Reeve, paralyzed five years ago after a fall during an equestrian competition, will discuss his life and...
Feb 10 2000
WASHINGTON, D.C. (February 11, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a...
Feb 8 2000
WASHINGTON, D.C. (February 8, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today on...


Biotechnology News

August 27, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology Announces 1:100 Reverse Stock Split

August 27, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small...

August 27, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group comments on inaccurate article. The author disclosed on the front page that he is “short” the Company’s stock, meaning...

August 27, 2014

MADISON, Wis.--(BUSINESS WIRE)--Madison Vaccines Inc.'s MVI-816 will be used in a trial testing a two-pronged approach to treat metastatic prostate cancer, conducted with...

August 27, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that a series of abstracts highlighting data from its Infectious Disease portfolio...